Clinical Trial Detail

NCT ID NCT04155840
Title Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Indications

chronic lymphocytic leukemia

CLL/SLL

Therapies

Bendamustine + Copanlisib + Rituximab

Age Groups: senior

No variant requirements are available.